Study to Evaluate IMG-004 in Healthy Participants

NCT05349097 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: SAD IMG-004 30mg
DRUG: SAD IMG-004 100mg
DRUG: SAD IMG-004 200mg
DRUG: SAD IMG-004 400mg
DRUG: SAD IMG-004 600mg
DRUG: SAD Placebo 30mg
DRUG: SAD Placebo 100mg
DRUG: SAD Placebo 200mg
DRUG: SAD Placebo 400mg
DRUG: SAD Placebo 600mg
DRUG: MAD IMG-004 50mg
DRUG: MAD Placebo 50mg
DRUG: MAD IMG-004 150mg
DRUG: MAD Placebo 150mg
DRUG: MAD IMG-004 300mg
DRUG: MAD Placebo 300mg
DRUG: FE IMG-004 150mg

Sponsor

Inmagene LLC